Phenoxyalkylamine and agricultural and horticultural bactericide
    5.
    发明授权
    Phenoxyalkylamine and agricultural and horticultural bactericide 失效
    苯氧基烷基胺和农业和园艺杀菌剂

    公开(公告)号:US5409957A

    公开(公告)日:1995-04-25

    申请号:US35903

    申请日:1993-03-23

    CPC分类号: A01N39/00 C07C217/20

    摘要: Disclosed are a phenoxyalkylamine represented by the following general formula I and a salt of said phenoxyalkylamine represented by the following general formula II: ##STR1## wherein R represents a linear saturated hydrocarbon having 7 to 12 carbon atoms, n is an integer of from 1 to 5, m is an integer of from 2 to 4, and HX represents a mineral acid.These compounds have strong bacteriostatic and bactericidal actions for plants with no phytotoxicity. Therefore, these compounds are effectively used as the active ingredient of an agricultural and horticultural bactericide.

    摘要翻译: 公开了由以下通式I表示的苯氧基烷基胺和由以下通式II表示的所述苯氧基烷基胺的盐:其中R表示具有7至12个碳原子的直链饱和烃,n是 1〜5的整数,m为2〜4的整数,HX表示无机酸。 这些化合物对没有植物毒性的植物具有很强的抑菌和杀菌作用。 因此,这些化合物有效地用作农业和园艺杀菌剂的活性成分。

    Process for producing oxazopyrroloquinolines, novel
oxazopyrroloquinolines, and use of oxazopyrroloquinolines
    7.
    发明授权
    Process for producing oxazopyrroloquinolines, novel oxazopyrroloquinolines, and use of oxazopyrroloquinolines 失效
    制备恶唑并吡咯并喹啉的方法,新型恶唑并吡咯啉喹啉和恶唑并吡咯啉喹啉的使用

    公开(公告)号:US5429940A

    公开(公告)日:1995-07-04

    申请号:US060240

    申请日:1993-07-12

    摘要: The present invention provides a process for producing oxazopyrroloquinolines which comprises culturing microorganisms to produce pyrroloquinolinequinone and adding .alpha.-amino acids or monomethylamine to the resulting culture broth which contains the pyrroloquinolinequinone and from which cells of microorganisms are not separated, thereby to convert the pyrroloquinolinequinone to the corresponding oxazopyrroloquinolines. The thus obtained oxazopyrroloquinolines include novel compounds. The present invention further provides aldose reductase inhibitors, diabetic combined disease curing agents, immunopotentiating agents and liver disease inhibiting agents which contain as active ingredient these oxazopyrroloquinolines having excellent physiological activity.

    摘要翻译: 本发明提供一种生产恶唑并吡咯并喹啉的方法,其包括培养微生物以产生吡咯并喹啉醌,并向所得的含有吡咯并喹啉醌的培养液中加入α-氨基酸或一甲基胺,并且微生物细胞未分离,从而将吡咯并喹啉醌转化为 对应的恶唑并吡咯啉喹啉。 由此获得的恶唑并吡咯啉喹啉包括新化合物。 本发明还提供了具有优异生理活性的醛糖还原酶抑制剂,糖尿病合并疾病固化剂,免疫增强剂和肝病抑制剂,其含有作为活性成分的恶唑吡咯并喹啉。

    Oxazopyrroloquinolines and use of oxazopyrroloquinolines
    9.
    发明授权
    Oxazopyrroloquinolines and use of oxazopyrroloquinolines 失效
    恶唑吡咯并喹啉和恶唑并吡咯啉喹啉的使用

    公开(公告)号:US5236930A

    公开(公告)日:1993-08-17

    申请号:US826220

    申请日:1992-01-23

    IPC分类号: C07D498/14 C12P17/18

    摘要: The present invention provides a process for producing oxazopyrroloquinolines which comprises culturing microorganisms to produce pyrroloquinolinequinone and adding .alpha.-amino acids or monomethylamine to the resulting culture broth which contains the pyrroloquinolinequinone and from which cells of microorganisms are not separated, thereby to convert the pyrroloquinolinequinone to the corresponding oxazopyrroloquinolines.The thus obtained oxazopyrroloquinolines include novel compounds.The present invention further provides aldose reductase inhibitors, diabetic combined disease curing agents, immunopotentiating agents and liver disease inhibiting agents which contain as active ingredient these oxazopyrroloquinolines having excellent physiological activity.

    摘要翻译: 本发明提供一种生产恶唑并吡咯并喹啉的方法,其包括培养微生物以产生吡咯并喹啉醌,并向所得的含有吡咯并喹啉醌的培养液中加入α-氨基酸或一甲基胺,并且微生物细胞未分离,从而将吡咯并喹啉醌转化为 对应的恶唑并吡咯啉喹啉。 由此获得的恶唑并吡咯啉喹啉包括新化合物。 本发明还提供了具有优异生理活性的醛糖还原酶抑制剂,糖尿病合并疾病固化剂,免疫增强剂和肝病抑制剂,其含有作为活性成分的恶唑吡咯并喹啉。